echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > JNCC: Hejie academician team released the latest cancer incidence and mortality data in China

    JNCC: Hejie academician team released the latest cancer incidence and mortality data in China

    • Last Update: 2022-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Academician Hejie published an article titled "Cancer Incidence and Mortality in China, 2016" at JNCC as the corresponding author
    .


    Based on the latest data from the National Cancer Center, the study selected 487 high-quality surveillance sites from 682 cancer surveillance sites across the country, covering a population of 380 million, and elaborated on the cancer disease burden in China in 2016


    Compared with 2015, the number of monitoring sites that reported statistical data increased by 181, and the number of high-quality monitoring sites increased by 119, indicating that the coverage of tumor registration in China has gradually advanced, and the quality and standardization of data have been further improved, providing better support for national health policy formulation.
    strong scientific basis
    .

    Statistics on the incidence of cancer in China in 2016

    basic situation

    basic situation

    New cases: 4.
    064 million

    4.
    064 million

    World standard occurrence rate: 1.
    8646/100,000

    Men are higher than women (207.
    03/100,000 vs 1.
    6814/100,000)

    Men are higher than women (207.
    03/100,000 vs 1.
    6814/100,000)

    gender difference

    gender difference gender difference

     

    age difference

    age difference age difference

    Men are higher than women: 0~19 years old, 60 years old and above

    Women are higher than men: 15-59 years old

    Peak: The peak of new cancer cases in both men and women is between 60 and 79 years old

     

    regional difference

    regional differences regional differences

    Overall urban higher than rural (1.
    897/100,000 vs 1.
    762/100,000)

    Cities are higher than rural areas: lung cancer , breast cancer ,Colorectal cancer , prostate cancer

    Cities are higher than rural areas: lung cancer , breast cancer ,Colorectal cancer , prostate cancer, lung cancer, breast cancercolorectal cancer

    Rural areas are higher than cities:Gastric cancer , liver cancer, cervical cancer, esophageal cancer

    Rural areas are higher than cities:Gastric cancer , liver cancer, cervical cancer, esophageal cancerstomach cancer

    Cancer deaths in my country in 2016

    Cancer deaths in China in 2016 Cancer deaths in China in 2016

    basic situation

    Total deaths: 2.
    414 million

    Total deaths: 2.
    414 million

    World Standard Death Rate: 105.
    19/100,000

    Men outnumber women (138.
    14/100,000 vs 73.
    95/100,000)

     

    gender difference

    gender difference gender difference

    All age groups: Men die more than women

    Men die more than women

    Death rate for women is higher than for men: gallbladder cancer, thyroid cancer

    Gallbladder cancer, Thyroid cancer

    Mortality in men is higher than in women: all other cancers

    All other cancers

     

    age difference

    age difference age difference

    Men are higher than women: 0~14 years old, 60 years old and above

    Women are higher than men: 15-59 years old

    Highest mortality rate: 60-79 years old

    regional difference

    regional differences regional differences

    Overall rural higher than urban (106.
    1/100,000 vs 102.
    8/100,000)

    Urban higher than rural:  lung, colorectal, breast, prostate cancer

    Lung, colorectal, breast, prostate cancer

    Rural areas are higher than urban areas: liver cancer, stomach cancer, esophageal cancer, cervical cancer 

    Liver cancer, stomach cancer, esophageal cancer, cervical cancer 

    Trends of cancer incidence and mortality in China from 2000 to 2016

    Trends of Cancer Incidence and Mortality in China from 2000 to 2016 Trends of Cancer Incidence and Mortality in China from 2000 to 2016

    Incidence trend

    Incidence trend

    rise:

    • Men: Prostate cancer, colorectal cancer, leukemia , brain tumor, pancreatic cancer , and bladder cancer

    • Women: Thyroid cancer, cervical cancer, uterine cancer, breast cancer, brain tumor, lung cancer, colorectal cancer

  • Men: Prostate cancer, colorectal cancer, leukemia , brain tumor, pancreatic cancer , and bladder cancer

  • Men: Prostate cancer, colorectal cancer, leukemia , brain tumor, pancreatic cancer , and bladder cancer

    Prostate, Colorectal, Leukemia , Brain Tumors, Pancreatic and Bladder Cancers Leukemia Pancreatic Cancer
  • Women: Thyroid cancer, cervical cancer, uterine cancer, breast cancer, brain tumor, lung cancer, colorectal cancer

  • Women: Thyroid cancer, cervical cancer, uterine cancer, breast cancer, brain tumor, lung cancer, colorectal cancer

    Thyroid cancer, cervical cancer, uterine cancer, breast cancer, brain tumor, lung cancer, colorectal cancer

    decline:

    • Men and women: esophagus, stomach, liver cancer

  • Men and women: esophagus, stomach, liver cancer

  • Men and women: esophagus, stomach, liver cancer

    Mortality Trend

    Mortality Trend

    rise:

    • Men: Prostate cancer, colorectal cancer, pancreatic cancer, leukemia

    • Women: Cervical cancer, thyroid cancer, breast cancer

  • Men: Prostate cancer, colorectal cancer, pancreatic cancer, leukemia

  • Men: Prostate cancer, colorectal cancer, pancreatic cancer, leukemia

    Prostate cancer, colorectal cancer, pancreatic cancer, leukemia
  • Women: Cervical cancer, thyroid cancer, breast cancer

  • Women: Cervical cancer, thyroid cancer, breast cancer

    Cervical cancer, thyroid cancer, breast cancer

    decline:

    • Men and women: esophagus, stomach, liver, lung

  • Men and women: esophagus, stomach, liver, lung

  • Men and women: esophagus, stomach, liver, lung

    Trends in incidence and mortality of selected cancers in men and women from 2000 to 2016
    .


    A: male incidence; B: female incidence; C: male mortality; D: female mortality


    summary summary

    incidence

    incidence
    • The overall crude incidence of cancer in my country continues to rise, reflecting the actual burden of cancer in my country;

    • The first incidence: lung cancer in men and breast cancer in women;

    • The incidence rate is higher in cities than in rural areas;

    • The traditional high incidence of esophageal cancer, gastric cancer, liver cancer and other tumors in China shows a continuous downward trend, but the disease burden is still heavy;

    • The incidence of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries is showing a continuous upward trend, and the prevention and control situation is grim


  • The overall crude incidence of cancer in my country continues to rise, reflecting the actual burden of cancer in my country;

  • The overall crude incidence of cancer in my country continues to rise, reflecting the actual burden of cancer in my country;

  • The first incidence: lung cancer in men and breast cancer in women;

  • The first incidence: lung cancer in men and breast cancer in women;

  • The incidence rate is higher in cities than in rural areas;

  • The incidence rate is higher in cities than in rural areas;

  • The traditional high incidence of esophageal cancer, gastric cancer, liver cancer and other tumors in China shows a continuous downward trend, but the disease burden is still heavy;

  • The traditional high incidence of esophageal cancer, gastric cancer, liver cancer and other tumors in China shows a continuous downward trend, but the disease burden is still heavy;

  • The incidence of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries is showing a continuous upward trend, and the prevention and control situation is grim


  • The incidence of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries is showing a continuous upward trend, and the prevention and control situation is grim


    mortality rate

    mortality rate
    • The crude cancer mortality rate in my country is still on the rise, but after adjusting the age structure of the population, the standardized mortality rate shows a downward trend, reflecting the preliminary results of comprehensive cancer prevention and control in my country in recent years;

    • Leading death: Lung cancer in both men and women;

    • Mortality rates in rural areas are higher than in urban areas;

    • The mortality rate of esophageal cancer, gastric cancer, liver cancer and other tumors with high incidence and poor prognosis in my country is decreasing year by year, but the mortality rate of cervical cancer is still on the rise;

    • The mortality rates of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries show a continuous upward trend


  • The crude cancer mortality rate in my country is still on the rise, but after adjusting the age structure of the population, the standardized mortality rate shows a downward trend, reflecting the preliminary results of comprehensive cancer prevention and control in my country in recent years;

  • The crude cancer mortality rate in my country is still on the rise, but after adjusting the age structure of the population, the standardized mortality rate shows a downward trend, reflecting the preliminary results of comprehensive cancer prevention and control in my country in recent years;

  • Leading death: Lung cancer in both men and women;

  • Leading death: Lung cancer in both men and women;

  • Mortality rates in rural areas are higher than in urban areas;

  • Mortality rates in rural areas are higher than in urban areas;

  • The mortality rate of esophageal cancer, gastric cancer, liver cancer and other tumors with high incidence and poor prognosis in my country is decreasing year by year, but the mortality rate of cervical cancer is still on the rise;

  • The mortality rate of esophageal cancer, gastric cancer, liver cancer and other tumors with high incidence and poor prognosis in my country is decreasing year by year, but the mortality rate of cervical cancer is still on the rise;

  • The mortality rates of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries show a continuous upward trend


  • The mortality rates of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries show a continuous upward trend


    Original source:

    Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, Chen R, Li L, Wei WQ, He J.


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.